Published in Cancer Weekly, February 13th, 1995
H. pylori is the bacteria which has been recognized by the U.S. National Institutes of Health, the World Health Organization (WHO) and the worldwide medical community as the principal cause of peptic ulcer disease and gastritis.
The OraVax oral vaccine is designed both as a cure and prevention for H. pylori infection, which in the United States alone affects 20 percent of the population between 20 and 30, and over 50 percent by the age of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.